View Older Stories View More Recent Stories

Jan 10, 2024 09:08AM Form SC 13G/A GLAUKOS Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
Jan 5, 2024 12:51PM Holding(s) in Company
Dec 29, 2023 04:13PM JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
Dec 20, 2023 08:00AM MBX Biosciences to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Dec 19, 2023 12:58PM Auto loans platform Lendbuzz hires banks for IPO, sources say
Dec 13, 2023 08:00AM BetterUp Achieves Data Privacy Framework Certification
Dec 13, 2023 01:13AM Factbox-Big investors spur consolidation, growth in EV charging sector
Dec 11, 2023 09:37AM Form SC 13G/A Patria Investments Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
Dec 11, 2023 09:37AM Form SC 13G/A Aclaris Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Dec 11, 2023 09:37AM Form SC 13G/A OMNICELL, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Dec 11, 2023 09:37AM Form SC 13G/A YETI Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Dec 11, 2023 09:37AM Form SC 13G/A National Bank Holdings Filed by: WELLINGTON MANAGEMENT GROUP LLP
Dec 5, 2023 08:00AM Supply Wisdom Fortifies Leadership to Accelerate Innovation and Growth
Dec 5, 2023 06:09AM Life insurers binge on US financing aimed at helping housing
Dec 1, 2023 11:50AM Form 13F-HR/A WELLINGTON MANAGEMENT For: Sep 30
Nov 28, 2023 09:51AM Holding(s) in Company
Nov 27, 2023 06:01AM FREYR Battery (FREY) Appoints Jessica Wirth Strine to its Board
Nov 27, 2023 06:01AM FREYR Battery Appoints Jessica Wirth Strine to Board of Directors
Nov 24, 2023 11:11AM Holding(s) in Company
Nov 15, 2023 03:00PM BetterUp’s Center for Purpose and Performance Announces Call for Submissions for Inaugural Research Prize
Nov 15, 2023 08:00AM MBX Biosciences to Participate in Piper Sandler 35th Annual Healthcare Conference
Nov 14, 2023 06:45PM Investors increase holdings of weight-loss drug makers’ shares in Q3 -filings
Nov 14, 2023 07:11AM Form 13F-HR WELLINGTON MANAGEMENT For: Sep 30
Nov 9, 2023 01:27PM Form SC 13G/A RUSH ENTERPRISES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 01:27PM Form SC 13G/A 2seventy bio, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 01:27PM Form SC 13G/A SP Plus Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 01:27PM Form SC 13G/A AGIOS PHARMACEUTICALS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 01:27PM Form SC 13G/A Revolution Medicines, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 01:27PM Form SC 13G/A OWENS & MINOR INC/VA/ Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 01:27PM Form SC 13G NEW YORK COMMUNITY BANCO Filed by: WELLINGTON MANAGEMENT GROUP LLP
Nov 9, 2023 11:38AM Holding(s) in Company
Nov 9, 2023 09:14AM Major Shareholder Announcement
Nov 8, 2023 11:09AM Major Shareholder Announcement
Nov 8, 2023 09:00AM BetterUp Manage™ Launches to Drive Personalized Manager Effectiveness at Scale
Nov 1, 2023 09:11AM Vanguard International Dividend Growth Fund Now Available for Investment
Nov 1, 2023 09:00AM Acadian Adds to Investment Team with Key Hires
Nov 1, 2023 08:00AM MBX Biosciences Announces Appointment of Michelle Graham as Chief Human Resources Officer
Oct 31, 2023 08:00AM MBX Biosciences to Participate in Stifel 2023 Healthcare Conference
Oct 25, 2023 08:30AM Wellington Management Expands Investment Platform With New CLO Offerings
Oct 23, 2023 12:00PM Wellington Management Announces Close of Wellington Venture Investments I
Oct 16, 2023 04:00PM MBX Biosciences Presents Positive Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Oct 16, 2023 09:00AM Hartford Funds Launches Hartford Quality Value ETF, After Completing Mutual Fund-to-ETF Conversion
Oct 10, 2023 11:03AM Form SC 13G/A StepStone Group Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Oct 9, 2023 08:00AM MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Oct 3, 2023 08:00AM MBX Biosciences to Showcase Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Sep 29, 2023 04:15PM JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
Sep 27, 2023 06:30AM Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
Sep 22, 2023 12:23PM Holding(s) in Company
Sep 18, 2023 09:00AM Hartford Funds Launches Its First Private-Equity-Focused Fund
Sep 11, 2023 08:00AM MBX Biosciences Announces Positive Phase 1 Multiple Ascending Dose Data for MBX 2109, a Long-Acting Parathyroid Hormone Peptide Prodrug, in Healthy Adults
View More Recent Stories View Older Stories